Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Williams

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
Nature|March 9, 2017
Aboriginal mitogenomes reveal 50,000 years of regionalism in AustraliaRay Tobler, Adam Rohrlach, Julien Soubrier, et al.
Journal of Medicinal Chemistry|January 5, 2012
Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonistsMohamed A Ibrahim, Henry W B Johnson, Joon Won Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2019
A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade GliomaPeter E Hall, Rachel Lewis, Nelofer Syed, et al.
Frontiers in Oncology|February 26, 2021
A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future ResearchThomas C Booth, Gerard Thompson, Helen Bulbeck, et al.
Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.
Cell Reports|February 14, 2025
A microRNA-regulated transcriptional state defines intratumoral CD8<sup>+</sup> T cells that respond to immunotherapyWilliam W Tang, Ben Battistone, Kaylyn M Bauer, et al.
Blood|May 28, 2024
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycleCarys S Johnson, Matthew Williams, Kendig Sham, et al.
Journal of Medicinal Chemistry|May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitorsJames W Leahy, Chris A Buhr, Henry W B Johnson, et al.
JACC. Clinical Electrophysiology|November 20, 2020
Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT SyndromeJeremy P Moore, Roberto G Gallotti, Kevin M Shannon, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
Nature|March 9, 2017
Aboriginal mitogenomes reveal 50,000 years of regionalism in AustraliaRay Tobler, Adam Rohrlach, Julien Soubrier, et al.
Journal of Medicinal Chemistry|January 5, 2012
Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonistsMohamed A Ibrahim, Henry W B Johnson, Joon Won Jeong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2019
A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade GliomaPeter E Hall, Rachel Lewis, Nelofer Syed, et al.
Frontiers in Oncology|February 26, 2021
A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future ResearchThomas C Booth, Gerard Thompson, Helen Bulbeck, et al.
Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.
Cell Reports|February 14, 2025
A microRNA-regulated transcriptional state defines intratumoral CD8<sup>+</sup> T cells that respond to immunotherapyWilliam W Tang, Ben Battistone, Kaylyn M Bauer, et al.
Blood|May 28, 2024
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycleCarys S Johnson, Matthew Williams, Kendig Sham, et al.
Journal of Medicinal Chemistry|May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitorsJames W Leahy, Chris A Buhr, Henry W B Johnson, et al.
JACC. Clinical Electrophysiology|November 20, 2020
Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT SyndromeJeremy P Moore, Roberto G Gallotti, Kevin M Shannon, et al.
Pageof 15